These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome. Yildirim H; Metintas M; Ak G; Erginel S; Alatas F; Kurt E; Metintas S; Ucgun I Lung; 2007 Dec; 185(6):349-54. PubMed ID: 17952507 [TBL] [Abstract][Full Text] [Related]
11. Pre-EDIT: A Randomized Feasibility Trial of Elastance-Directed Intrapleural Catheter or Talc Pleurodesis in Malignant Pleural Effusion. Martin GA; Tsim S; Kidd AC; Foster JE; McLoone P; Chalmers A; Blyth KG Chest; 2019 Dec; 156(6):1204-1213. PubMed ID: 31374208 [TBL] [Abstract][Full Text] [Related]
12. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial. Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255 [TBL] [Abstract][Full Text] [Related]
13. [Chinese expert consensus on treatment of malignant pleural effusion (2023 Edition)]. Chinese Thoracic Society, Chinese Medical Association Zhonghua Jie He He Hu Xi Za Zhi; 2023 Dec; 46(12):1189-1203. PubMed ID: 38044047 [TBL] [Abstract][Full Text] [Related]
14. Recommendations of the Spanish Society of Thoracic Surgery for the management of malignant pleural effusion. Recuero Díaz JL; Figueroa Almánzar S; Gálvez Muñoz C; Lázaro Sierra J; López Porras M; Márquez Medina D; Nabal Vicuña M; Sánchez Moreno L; González Cantalejo M; Porcel JM Cir Esp (Engl Ed); 2022 Nov; 100(11):673-683. PubMed ID: 35667609 [TBL] [Abstract][Full Text] [Related]
15. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Janssen JP; Collier G; Astoul P; Tassi GF; Noppen M; Rodriguez-Panadero F; Loddenkemper R; Herth FJ; Gasparini S; Marquette CH; Becke B; Froudarakis ME; Driesen P; Bolliger CT; Tschopp JM Lancet; 2007 May; 369(9572):1535-1539. PubMed ID: 17482984 [TBL] [Abstract][Full Text] [Related]
16. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion. Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235 [TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14). Boshuizen RC; Vd Noort V; Burgers JA; Herder GJM; Hashemi SMS; Hiltermann TJN; Kunst PW; Stigt JA; van den Heuvel MM Lung Cancer; 2017 Jun; 108():9-14. PubMed ID: 28625655 [TBL] [Abstract][Full Text] [Related]
18. Interventions to treat malignant pleural effusions. Lenker A; Mayer DK; Bernard SA Clin J Oncol Nurs; 2015 Oct; 19(5):501-4. PubMed ID: 26414568 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of talc pleurodesis for malignant pleural effusion: a meta-analysis. Xia H; Wang XJ; Zhou Q; Shi HZ; Tong ZH PLoS One; 2014; 9(1):e87060. PubMed ID: 24475222 [TBL] [Abstract][Full Text] [Related]
20. Indwelling pleural catheter versus talc pleurodesis for malignant pleural effusion: a meta-analysis. Yeung M; Loh EW; Tiong TY; Tam KW Clin Exp Metastasis; 2020 Aug; 37(4):541-549. PubMed ID: 32524317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]